MENU
+Compare
BPMUF
Stock ticker: OTC
AS OF
Jul 30 closing price
Price
$67.75
Change
+$6.41 (+10.45%)
Capitalization
903M

BPMUF Basilea Pharmaceutica AG Forecast, Technical & Fundamental Analysis

Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing drugs to meet the needs of patients with severe bacterial and fungal infections... Show more

BPMUF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for BPMUF with price predictions
Feb 04, 2026

Momentum Indicator for BPMUF turns positive, indicating new upward trend

BPMUF saw its Momentum Indicator move above the 0 level on January 21, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 12 similar instances where the indicator turned positive. In of the 12 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Aroon Indicator entered an Uptrend today. In of 72 cases where BPMUF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for BPMUF moved out of overbought territory on January 29, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 7 similar instances where the indicator moved out of overbought territory. In of the 7 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 16 cases where BPMUF's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for BPMUF turned negative on February 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 16 similar instances when the indicator turned negative. In of the 16 cases the stock turned lower in the days that followed. This puts the odds of success at .

BPMUF broke above its upper Bollinger Band on January 26, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BPMUF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.553) is normal, around the industry mean (26.526). P/E Ratio (10.053) is within average values for comparable stocks, (51.406). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.895). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (3.234) is also within normal values, averaging (329.988).

View a ticker or compare two or three
BPMUF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Hegenheimermattweg 167b
Phone
+41 616061111
Employees
147
Web
https://www.basilea.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LEQCX9.880.11
+1.13%
LoCorr Dynamic Opportunity C
PBEAX24.880.03
+0.12%
PGIM Jennison Value A
TRZZX60.73-0.06
-0.10%
T. Rowe Price Small-Cap Stock Z
QQMNX21.84-0.04
-0.18%
Federated Hermes MDT Market Neutral IS
RWCEX15.95-0.19
-1.18%
Redwheel Global Emerging Equity Ins

BPMUF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BPMUF has been loosely correlated with AAVXF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if BPMUF jumps, then AAVXF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BPMUF
1D Price
Change %
BPMUF100%
N/A
AAVXF - BPMUF
47%
Loosely correlated
N/A
ALZN - BPMUF
36%
Loosely correlated
-3.69%
GTBP - BPMUF
29%
Poorly correlated
+2.29%
NCNA - BPMUF
28%
Poorly correlated
-6.98%
ADIL - BPMUF
28%
Poorly correlated
-1.58%
More